Your browser doesn't support javascript. This means that the content or functionality of our website will be limited or unavailable. If you need more information about Vinnova, please contact us.

ASTAR - Acute Stroke Treatment and Recovery

Reference number
Coordinator EDVINCE AKTIEBOLAG
Funding from Vinnova SEK 500 000
Project duration July 2017 - December 2017
Status Completed

Purpose and goal

The project consisted of three overarching tasks: Task 1 - To define study requirements and prepare Phase I/IIa study to be undertaken in the Phase 2 project, and to review Edvince´s current state and external environment, and gain an understanding of the European and international markets and competition; Task 2 - To develop a business strategy in accordance with Edvince´s vision, values and long-term development & revenue goals; Task 3 - To formulate the final business strategy and the business plan.

Expected results and effects

The project resulted in the completion of a Phase I/II clinical trial application for submission to the competent authority. The project also resulted in a comprehensive understanding of the market and the landscape Edvince is acting within, and established a foundation for the continued development of the business in relation to the market forces at play. The outcome of the tasks is a more refined business strategy and alignment of the business plan in accordance with the new learnings as well as a thorough plan to reach the next inflection point.

Planned approach and implementation

The project was divided in three major tasks, where task 1 was conducted by Edvince in conjunction with expert consultants, task 2 and 3 were conducted the Edvince. Task 1 established a foundation for the two subsequent activities, and was facilitated considerably by the expertise that was engaged both qualitatively and timewise.

The project description has been provided by the project members themselves and the text has not been looked at by our editors.

Last updated 25 November 2019

Reference number 2017-03371

Page statistics